These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10667674)

  • 1. Evaluation of 201T1 SPECT for predicting early treatment response in patients with squamous cell carcinoma of the extracranial head and neck treated with nonsurgical organ preservation therapy: initial results.
    Mukherji SK; Gapany M; Neelon B; McCartney W
    J Comput Assist Tomogr; 2000; 24(1):146-51. PubMed ID: 10667674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck.
    Mukherji SK; Gapany M; Phillips D; Neelon B; O'Brien S; McCartney W; Buejenovich S; Parekh JS; Noordzij JP; Castillo M
    AJNR Am J Neuroradiol; 1999 Aug; 20(7):1215-20. PubMed ID: 10472974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thallium-201 SPECT in the diagnosis of head and neck cancer.
    Valdés Olmos RA; Balm AJ; Hilgers FJ; Koops W; Loftus BM; Tan IB; Muller SH; Hoefnagel CA; Gregor RT
    J Nucl Med; 1997 Jun; 38(6):873-9. PubMed ID: 9189132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
    Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
    Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thallium-201 single-photon emission CT in recurrent squamous cell carcinoma of the head and neck.
    O'Tuama LA; Poussaint TY
    AJNR Am J Neuroradiol; 2002 Jan; 23(1):174-5. PubMed ID: 11827893
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlative 201Tl SPECT, MRI and ex vivo 201Tl uptake in detecting and characterizing cervical lymphadenopathy in head and neck squamous cell carcinoma.
    Valdés Olmos RA; Koops W; Loftus BM; Liem IH; Gregor RT; Hoefnagel CA; Hilgers FJ; Balm AJ
    J Nucl Med; 1999 Sep; 40(9):1414-9. PubMed ID: 10492358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult primary tumors of the head and neck: accuracy of thallium 201 single-photon emission computed tomography and computed tomography and/or magnetic resonance imaging.
    van Veen SA; Balm AJ; Valdés Olmos RA; Hoefnagel CA; Hilgers FJ; Tan IB; Pameijer FA
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):406-11. PubMed ID: 11296049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
    Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
    J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult primary tumors of the head and neck: detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT.
    Mukherji SK; Drane WE; Mancuso AA; Parsons JT; Mendenhall WM; Stringer S
    Radiology; 1996 Jun; 199(3):761-6. PubMed ID: 8638002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [201T1 single photon emission computed tomography in the diagnosis of lung cancer].
    Tonami N; Hisada K; Watanabe Y; Suzuki M; Takashima T; Nonomura A; Kitagawa M
    Rinsho Hoshasen; 1990 Jul; 35(7):825-32. PubMed ID: 2169553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.
    Sonoda Y; Kumabe T; Takahashi T; Shirane R; Yoshimoto T
    Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.
    Brkovich VS; Miller FR; Karnad AB; Hussey DH; McGuff HS; Otto RA
    Laryngoscope; 2006 Jun; 116(6):855-8. PubMed ID: 16735902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [201Thalium SPECT in the detection of recurrent laryngeal carcinoma].
    Negre Busó M; Lorente Guerrero J; Rubió Rodríguez A; García López M; González Doñate M; Boronat de Ferrater M; Castell Conesa J
    Rev Esp Med Nucl; 2011; 30(4):236-40. PubMed ID: 21546128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
    Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO
    Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
    Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K
    AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?
    Zima A; Carlos R; Gandhi D; Case I; Teknos T; Mukherji SK
    AJNR Am J Neuroradiol; 2007 Feb; 28(2):328-34. PubMed ID: 17297007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of subclinical recurrence or second primary cancer using (18) F-FDG PET/CT in patients treated curatively for head and neck squamous cell carcinoma.
    Kikuchi M; Shinohara S; Hino M; Itoh K; Tona R; Kishimoto I; Harada H; Fujiwara K; Suehiro A; Naito Y
    Head Neck; 2016 Apr; 38 Suppl 1():E511-8. PubMed ID: 25783743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.